.
MergerLinks Header Logo

New Deal

New Deal

Cover Image Amit Sinha
Amit SinhaGOLDMAN SACHS ASSET MANAGEMENT

Amit Sinha

Managing Director and Head of Biotechnology at GOLDMAN SACHS ASSET MANAGEMENT

Investor

Deal Bio

Total Deals3
Valued Deals3
Total Value£6,043M
Avg. Deal Size£2,014M

Expertise (3)

Key Relationships

United States
Biotechnology
PublicAcquisitionMergerMajority
Avexis

target

Avexis

Novartis

bidder

Novartis

£5,275m

60 dealmakers

Switzerland
Biotechnology
PrivateAcquisitionMajority
Therachon Holding

target

Therachon Holding

Pfizer

bidder

Pfizer

£645m

48 dealmakers

United States
Biotechnology
AcquisitionVenture CapitalCross BorderPrivatePrivate EquityMinority
Moma Therapeutics

target

Moma Therapeutics

Rock Springs Capital

bidder

Rock Springs Capital

£121m

14 dealmakers

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US